ERBB2 and breast carcinoma: On the basis of differences in gene expression patterns, breast cancer can be divided into four clinical subtypes that have significant implications for treatment and prognosis: luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) overexpression, and basal-like subtypes (1, 2).